-

Korian Creates the 3rd European Mental Health Platform After Completing Its Acquisition of Ita Salud Mental

  • Third largest1 mental health player in Spain

- 39 sites in key locations including Madrid and Valencia

- 27 inpatient clinics with c.900 beds and 12 outpatient clinics with a capacity for 10,000 sessions per month

- Expected 2021 revenue c. €50 million and accretive to Group margins

- High embedded growth with an expected CAGR of c.15% in revenue until 2024

  • Creation of the 3rd pan-European mental health platform

- Expected 2022 revenue c. 250 millions in France, Spain and Italy

- Embedded growth c.10%

PARIS--(BUSINESS WIRE)--Regulatory News:

Korian (Paris:KORI), the leading European care services group for elderly and fragile people, has completed its acquisition of Ita Salud Mental from Magnum Capital, after obtaining the necessary regulatory and antitrust approvals.

Ita Salud Mental is a group specialised in mental health with 39 facilities across Spain. Ita Salud Mental is the third largest player in Spain by number of beds or second largest by revenue, with a strong presence particularly in Catalonia, Madrid and Valencia.

The network includes 27 inpatient clinics and 12 day hospitals (including 2 antennas) with reputed specialisations in behavioural, personality and eating disorders, addictions and neurodevelopment and general psychiatry.

Following the acquisition of Inicea, a major player in France, in December 2020, Korian pursues its development in mental health and creates the 3rd European platform with a presence in France, Spain and Italy, with a clear focus on innovative, specialised care solutions in an inpatient and outpatient environment.

From 2022 Korian expects to have revenue of around € 250 million from mental health care within the Group and will continue to invest in innovative care in this area to provide solutions to the growing needs, particularly in a post Covid environment.

Indeed, mental health conditions, from addictions, to mood disorders, eating disorders and more severe psychiatric diseases, are today one of the leading causes of chronic diseases in Europe. 15% of the European population suffers from one form or other of mental health conditions and prevalence of these pathologies is expected to continue rising given the ongoing pandemic.

About Korian

Korian, the leading European care services group for elderly and fragile people. www.korian.com

Korian has been listed on Euronext Paris Section A since November 2006 and is included in the following indices: SBF 120, CAC Health Care, CAC Mid 60, CAC Mid & Small and MSCI Global Small Cap

Euronext ticker: KORI - ISIN: FR0010386334 – Reuters: KORI.PA – Bloomberg: KORI.FP

1 By number of beds

Contacts

INVESTOR RELATIONS

Sarah Mingham
VP Investor Relations
& Financing
sarah.mingham@korian.com
Tel: +33 (0)1 55 37 53 55

Carole Alexandre
Deputy Head of
Investor Relations
carole.alexandre@korian.com
Tel: +33 (0)7 64 65 22 44

MEDIA CONTACTS

Jean-Marc Plantade
Head of Press Relations
jean-marc.plantade@korian.fr
Tel: +33 (0)7 62 90 32 58

Cyrille Lachèvre
Deputy Head of Press Relations
cyrille.lachevre@korian.fr
Tel: +33 (0)7 61 53 54 86

Marjorie Castoriadis
Head of Media Relations
marjorie.castoriadis@korian.fr
Tel: +33 (0)7 63 59 88 81

Korian

BOURSE:KORI

Release Versions

Contacts

INVESTOR RELATIONS

Sarah Mingham
VP Investor Relations
& Financing
sarah.mingham@korian.com
Tel: +33 (0)1 55 37 53 55

Carole Alexandre
Deputy Head of
Investor Relations
carole.alexandre@korian.com
Tel: +33 (0)7 64 65 22 44

MEDIA CONTACTS

Jean-Marc Plantade
Head of Press Relations
jean-marc.plantade@korian.fr
Tel: +33 (0)7 62 90 32 58

Cyrille Lachèvre
Deputy Head of Press Relations
cyrille.lachevre@korian.fr
Tel: +33 (0)7 61 53 54 86

Marjorie Castoriadis
Head of Media Relations
marjorie.castoriadis@korian.fr
Tel: +33 (0)7 63 59 88 81

More News From Korian

Clariane: Availability and Consultation of the Information Relating to the Combined General Meeting to Be Held on 14 May 2025

PARIS--(BUSINESS WIRE)--Regulatory News: Clariane (CLARI.PA - ISIN: FR0010386334) informs its shareholders that a Combined General Meeting (the "General Meeting") of the Company will take place on Wednesday 14 May 2025 at 2 p.m. in the meeting room Apostrophe, located at 83 avenue Marceau, 75016 Paris. The prior notice of the General Meeting containing the agenda, the draft resolutions presented by the Board of Directors and the description of the participation and voting arrangements for the G...

Clariane: Information on the Availability of the 2024 Universal Registration Document

PARIS--(BUSINESS WIRE)--Regulatory News: Clariane (CLARI.PA - ISIN: FR0010386334) announces the release of its 2024 Universal Registration Document. The 2024 Universal Registration Document was filed with the French Financial Markets Authority on 31 March 2025 in ESEF format, under number D.25-0209. This 2024 Universal Registration Document, established for the financial year ended on 31 December 2024, includes in particular: - the annual financial report and the integrated report, - the report...

Clariane: Governance Evolution - Mrs Sylvia Metayer, Independent Director, Appointed Chairwoman of the Board of Directors With Effect From May 14th, 2025

PARIS--(BUSINESS WIRE)--Regulatory News: Clariane (CLARI.PA - ISIN: FR0010386334) today announces a change in its corporate governance, with the appointment of Sylvia Metayer, an independent director, as Chairwoman of the Board of Directors at the close of the Annual General Meeting on 14 May 2025. Jean-Pierre Duprieu having indicated that he did not wish to be reappointed as Director at the Annual General Meeting of 14 May 2025, in anticipation of the statutory age limit of 75, the Board of Di...
Back to Newsroom